Seaport Global Advisors, LLC Seagen Inc. Transaction History

Seaport Global Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $98,244 - $110,890	513 New	513 $108,000
Q1 2023 May 23, 2023	BUY	$127.59 - $203.08 $179,774 - $286,139	1,409 Added 86.55%	3,037 $614,000
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $7,159 - $8,489	61 Added 3.89%	1,628 $209,000
Q3 2022 Nov 21, 2022	SELL	$135.27 - $180.11 $134,187 - $178,669	-992 Reduced 38.77%	1,567 $214,000
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $25,135 - $41,425	231 Added 9.92%	2,559 $453,000

Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $1.71 Million - $2.26 Million	-14,327 Reduced 86.02%	2,328 $335,000
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $2.37 Million - $3.18 Million	16,655 New	16,655 $2.58 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Seaport Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Seaport Global Advisors, LLC with notifications on news.